Treatment of Pre cancer condition affecting the cervix of Uterus with Bhandira churna
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: N72- Inflammatory disease of cervix uteri
- Registration Number
- CTRI/2022/12/047883
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Females with clinical signs & symptoms like white discharge p/v, lower abdominal pain, low back ache, dyspareunia, contact bleeding, hypertrophy of cervix, cervical erosion, cervicitis and diagnosed with cervical cell pathology of Low grade Squamous Intraepithelial Lesion/ ASCUS /Koilocytic atypia/ CIN I as per The Bethesda System Terminology
Exclusion Criteria
1.Females diagnosed with HSIL/ CIN II/ CIN III/ Carcinoma in situ (CIS)
2.Diagnosed cases of CA cervix
3.Females diagnosed with TB, STD & HIV
4.Pregnant and lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 20 percentage Regression in VIA Pap smear and Colposcopy findings <br/ ><br>Comparative efficacy of group A & B <br/ ><br>Timepoint: 4 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Change in signs and symptoms discharge per vaginum vulval itching Burning micturition dyspareunia burning micturition lower abdominal pain low back ache and cervical erosionTimepoint: 4 months